methionine has been researched along with 18f-faza in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balkay, L; Emri, M; Goda, K; Juhász, I; Krasznai, Z; Krasznai, ZT; Lajtos, I; Márián, T; Mikecz, P; Miklovicz, T; Németh, E; Szabó, G; Szalóki, G; Trencsényi, G | 1 |
| Anzalone, N; Barbera, M; Bettinardi, V; Castellano, A; Fallanca, F; Gianolli, L; Incerti, E; Mapelli, P; Picchio, M; Scifo, P | 1 |
2 other study(ies) available for methionine and 18f-faza
| Article | Year |
|---|---|
18FDG, [18F]FLT, [18F]FAZA, and 11C-methionine are suitable tracers for the diagnosis and in vivo follow-up of the efficacy of chemotherapy by miniPET in both multidrug resistant and sensitive human gynecologic tumor xenografts.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoradiography; Carbon Radioisotopes; Cell Line, Tumor; Dideoxynucleosides; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Fluorodeoxyglucose F18; Follow-Up Studies; Genital Neoplasms, Female; Humans; Methionine; Mice; Mice, SCID; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Hypoxia and Amino Acid Imaging of High-Grade Glioma: 18F-FAZA PET/CT and 11C-Methionine PET/MRI.
Topics: Adult; Amino Acids; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neoplasm Grading; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Tumor Hypoxia | 2020 |